Semiclotin

    verified Blood coagulation factors

    Semiclotin — package

    info General information

    Name Semiclotin, 1.2 mg, 2.4 mg, lyophilisate for solution for intravenous administration, supplied with solvent (water for injections)
    INN Eptacog alfa (activated)
    Active substance Eptacog alfa (activated)
    Pharmacotherapeutic group Antihemorrhagics. Vitamin K and other hemostatics. Blood coagulation factors. Eptacog alfa (activated).
    Dosage form Lyophilisate for solution for intravenous administration, supplied with solvent (water for injections)
    Packaging

    1.2 mg or 2.4 mg of the product in vials. 5 mL of solvent (water for injections) in vials. 1 vial with the product and 1 vial with the solvent are placed in a blister pack. 1 blister pack is placed in a cardboard box together with disposable medical supplies: a three-component syringe with a fitted or enclosed needle (2 mL for the 1.2 mg dose, 5 mL for the 2.4 mg dose), a peripheral venous catheter (infusion cannula (butterfly needle) for intravenous access with an extension line or an infusion cannula with an injection port for intravenous access), 1 injection filter cannula, 2 alcohol wipes placed in a polyethylene bag.

    Manufacturer Karaganda Pharmaceutical Complex LLP EU GMP

    assignment_turned_in Indications

    Semiclotin is used in adults and children:

    1. to stop and prevent bleeding during surgical interventions and invasive procedures in the following groups of patients:

    • patients born with hemophilia who do not respond to treatment with coagulation factors VIII or IX;
    • patients with acquired hemophilia;
    • patients with coagulation factor VII deficiency;
    • patients with Glanzmann's thrombasthenia (a blood clotting disorder) whose condition cannot be effectively treated by platelet transfusion, or if platelet transfusion is not available.

    2. to treat massive postpartum hemorrhage when the use of uterotonics is insufficient to achieve hemostasis.